The Effect of ZD 1839 (Iressa(R)) in the Treatment of Refractory Non Small Cell Lung Cancer
Yong Tai Kim, Chul Kim, Joo Hyuk Sohn, So Young Park, Soo Young Park, Nae Choon Yu, Young Sam Kim, Se Kyu Kim, Joon Chang, Kil Dong Kim, Kyung Young Chung, Joo Hang Kim
Cancer Res Treat. 2003;35(6):502-506. Published online 2003 Dec 31 DOI: https://doi.org/10.4143/crt.2003.35.6.502
Citations to this article as recorded by 
Serum Carcinoembryonic Antigen as an Index of the Therapeutic Effect of EGFR-TKIs in Patients with Advanced Non-Small Cell Lung Cancer
Jin Hee Park, Sung Bin Kim, Sung Jin Nam, Su Hyeon Jeong, Chul Ho Oak, Tae Won Jang, Maan Hong Jung
Journal of Lung Cancer.2010; 9(2): 97. CrossRef
A review of the benefit–risk profile of gefitinib in Asian patients with advanced non‐small‐cell lung cancer
Keunchil Park, Koichi Goto
Current Medical Research and Opinion.2006; 22(3): 561. CrossRef